Antigenotoxicity and Cytotoxic Potentials of Metabiotics Extracted from Isolated Probiotic,Lactobacillus rhamnosus MD 14 on Caco-2 and HT-29 Human Colon Cancer Cells
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Probiotics, the beneficial bacteria produce active metabolites which could probably mimic their anticancer effect and prevent the risk associated with live bacteria. Thus, the study was designed to isolate effective lactic acid bacteria (LAB) and monitor anticancerous potential of their metabiotic extracts. Probiotics were isolated from different sources and their cell free supernatants (CFS) were screened for antigenotoxic and cytotoxic potentials using SOS Chromo Test and MTT assay on Caco-2 and HT-29 cells. Organic extracts of CFS were prepared and dissolved in different solvents. The isolate with most effective metabiotic extract in terms of cytotoxicity was classified for probiotic and phylogenetic characters and the metabiotic extract was characterized physiochemically. Among 60 isolated LAB, CFS of only 10 isolates showed antigenotoxicity more than 30% and four exhibited 70–80% cytotoxicity. Further, organic extracts of these four CFS dissolved in carboxymethyl cellulose showed 80–90% cytotoxicity. Interestingly, the most effective isolate was found to possess probiotic attributes and phylogenetic characterization revealed it to be Lactobacillus rhamnosus MD 14. Physiochemical characterization of its metabiotic extract indicated the presence of heat sensitive organic acids and proteins. To conclude, metabiotics produced by isolated probiotic L. rhamnosus MD 14 exhibited both antigenotoxic and cytotoxic potential against colon cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Doron, S., & Snydman, D. R. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ085 · Cited by 942
Probiotic use in clinical practice: what are the risks?
Boyle, R. J., Robins-Browne, R. M., & Tang, M. L. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1256 · Cited by 776 · cited 1×
“Though probiotics have been found to be beneficial in CRC potential side effects such as bloating, excessive immune stimulation, systemic infections, septicemia or transfer of antibiotic resistance in certain individuals limit their application and metabiotics are gaining importance as an alternative agent (10,11).”
BackgroundJan, G., Belzacq, A.-S., Haouzi, D., Rouault, A., Métivier, D., Kroemer, G., & Brenner, C. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400935 · Cited by 385 · cited 1×
“on HT-29 cell lines was attributed to short chain fatty acids, mainly propionate and acetate (34,35).”
Background“Blooming” in the gut: how dysbiosis might contribute to pathogen evolution.
Stecher, B., Maier, L., & Hardt, W.-D. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2989 · Cited by 378
Cited by
Salminen, S., Collado, M. C., Endo, A., Hill, C., Lebeer, S., Quigley, E. M. M., Sanders, M. E., Shamir, R., Swann, J. R., Szajewska, H., et al. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00440-6 · Cited by 2,488
Swanson, K. S., Gibson, G. R., Hutkins, R., Reimer, R. A., Reid, G., Verbeke, K., Scott, K. P., Holscher, H. D., Azad, M. B., Delzenne, N. M., et al. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0344-2 · Cited by 2,196
Postbiotics: Current Trends in Food and Pharmaceutical Industry
Thorakkattu, P., Khanashyam, A. C., Shah, K., Babu, K. S., Mundanat, A. S., Deliephan, A., Deokar, G. S., Santivarangkna, C., & Nirmal, N. P. (2022) · Foods · doi:10.3390/foods11193094 · Cited by 380
Potential Pharmaceutical and Food Applications of Postbiotics: A Review
Rad, A. H., Abbasi, A., Kafil, H. S., & Ganbarov, K. (2020) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201021666200516154833 · Cited by 113
Chandel, D., Sharma, M., Chawla, V., Sachdeva, N., & Shukla, G. (2019) · Scientific Reports · doi:10.1038/s41598-019-51361-z · Cited by 67
Self-citation
Metadata
- Authors
- Sharma, M., Chandel, D., & Shukla, G.
- Venue
- Nutrition and Cancer
- Publisher
- Informa UK Limited
- Published
- 2019-07-03
- Volume
- 72
- Issue
- 1
- Pages
- 110-119
- ISSN
- 0163-5581 (ISSN-L)
- 1532-7914
- OpenAlex
- W2953983247
- Cited by
- 73
- References
- 4
- FWCI
- 6.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antigenotoxicity and Cytotoxic Potentials of Metabiotics Extracted from Isolated Probiotic,Lactobacillus rhamnosus MD 14 on Caco-2 and HT-29 Human Colon Cancer Cells. https://app.cochat.ai/papers/10.1080/01635581.2019.1615514
- The paper
- Sharma, M., Chandel, D., & Shukla, G. (2020). Antigenotoxicity and Cytotoxic Potentials of Metabiotics Extracted from Isolated Probiotic,Lactobacillus rhamnosus MD 14 on Caco-2 and HT-29 Human Colon Cancer Cells. Nutrition and Cancer. https://doi.org/10.1080/01635581.2019.1615514
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.